BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30680340)

  • 1. Follicle-Stimulating Hormone Is an Autocrine Regulator of the Ovarian Cancer Metastatic Niche Through Notch Signaling.
    Gera S; Kumar S S; Swamy SN; Bhagat R; Vadaparty A; Gawari R; Bhat R; Dighe RR
    J Endocr Soc; 2019 Feb; 3(2):340-357. PubMed ID: 30680340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
    Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y
    Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway.
    Zhang Z; Zhu Y; Lai Y; Wu X; Feng Z; Yu Y; Bast RC; Wan X; Xi X; Feng Y
    Int J Oncol; 2013 Oct; 43(4):1194-204. PubMed ID: 23921511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone.
    Zheng W; Lu JJ; Luo F; Zheng Y; Feng Yj; Felix JC; Lauchlan SC; Pike MC
    Gynecol Oncol; 2000 Jan; 76(1):80-8. PubMed ID: 10620446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular stimulating hormone enhances Notch 1 expression in SK-OV-3 ovarian cancer cells.
    Park YH; Kim SJ; Jeong BH; Herzog TJ; Wright J; Kitajewski J; Rhim CC; Jang PR; Kang JB; Kim SJ
    J Gynecol Oncol; 2010 Jun; 21(2):119-24. PubMed ID: 20613903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer.
    Parrott JA; Doraiswamy V; Kim G; Mosher R; Skinner MK
    Mol Cell Endocrinol; 2001 Feb; 172(1-2):213-22. PubMed ID: 11165055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase.
    Song K; Dai L; Long X; Wang W; Di W
    Sci Rep; 2020 Aug; 10(1):13834. PubMed ID: 32796926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variations altering FSH action affect circulating hormone levels as well as follicle growth in healthy peripubertal girls.
    Busch AS; Hagen CP; Almstrup K; Main KM; Juul A
    Hum Reprod; 2016 Apr; 31(4):897-904. PubMed ID: 26905078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progranulin expression induced by follicle-stimulating hormone in ovarian cancer cell lines depends on the histological subtype.
    Perez-Juarez CE; Arechavaleta-Velasco F; Mendez C; Díaz-Cueto L
    Med Oncol; 2020 May; 37(7):59. PubMed ID: 32474861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells.
    Ji Q; Liu PI; Chen PK; Aoyama C
    Int J Cancer; 2004 Dec; 112(5):803-14. PubMed ID: 15386376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype.
    Cheung J; Lokman NA; Abraham RD; Macpherson AM; Lee E; Grutzner F; Ghinea N; Oehler MK; Ricciardelli C
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
    Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
    Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target.
    Perales-Puchalt A; Svoronos N; Rutkowski MR; Allegrezza MJ; Tesone AJ; Payne KK; Wickramasinghe J; Nguyen JM; O'Brien SW; Gumireddy K; Huang Q; Cadungog MG; Connolly DC; Tchou J; Curiel TJ; Conejo-Garcia JR
    Clin Cancer Res; 2017 Jan; 23(2):441-453. PubMed ID: 27435394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicle-stimulating hormone receptors expression in ovine corpora lutea during luteal phase: effect of nutritional plane and follicle-stimulating hormone treatment.
    Grazul-Bilska AT; Dorsam ST; Reyaz A; Valkov V; Bass CS; Kaminski SL; Redmer DA
    Domest Anim Endocrinol; 2020 Apr; 71():106391. PubMed ID: 31731250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of FSHR in chondrocytes and the effect of FSH on chondrocytes.
    Kong D; Guan Q; Li G; Xin W; Qi X; Guo Y; Zhao J; Xu J; Sun S; Gao L
    Biochem Biophys Res Commun; 2018 Jan; 495(1):587-593. PubMed ID: 29133260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FSH receptor binding inhibitor restrains follicular development and possibly attenuates carcinogenesis of ovarian cancer through down-regulating expression levels of FSHR and ERβ in normal ovarian tissues.
    Zhuandi G; Tuanjie C; Luju L; Abdiryim A; Yingying D; Haoqin L; Suocheng W; Li D
    Gene; 2018 Aug; 668():174-181. PubMed ID: 29783074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer.
    Urbanska K; Stashwick C; Poussin M; Powell DJ
    Cancer Immunol Res; 2015 Oct; 3(10):1130-7. PubMed ID: 26112923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary study on pathway of follicle-stimulating hormone on human epithelial ovarian cancer cell proliferation].
    Sheng L; Liu DY; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):752-5. PubMed ID: 14728848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR).
    Ben-Josef E; Yang SY; Ji TH; Bidart JM; Garde SV; Chopra DP; Porter AT; Tang DG
    J Urol; 1999 Mar; 161(3):970-6. PubMed ID: 10022736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmocollin 3 mediates follicle stimulating hormone-induced ovarian epithelial cancer cell proliferation by activating the EGFR/Akt signaling pathway.
    Yang X; Wang J; Li WP; Jin ZJ; Liu XJ
    Int J Clin Exp Pathol; 2015; 8(6):6716-23. PubMed ID: 26261554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.